_version_ 1783290739603537920
author Steegmann, Juan Luis
Colomer, Dolors
Gómez-Casares, Maria-Teresa
García-Gutiérrez, Valentín
Ortí, Guillermo
Ramírez-Payer, Angel
Olavarria, Eduardo
Vall-llovera, Ferrán
Giraldo, Pilar
Conde, Eulogio
Vallansot, Rolando
López-Lorenzo, Jose Luis
Palomera, Luis
Álvarez-Larrán, Alberto
Conesa, Venancio
Bautista, Guiomar
Casas, Laura
Giles, Frank
Hochhaus, Andreas
Casado-Montero, Luis Felipe
author_facet Steegmann, Juan Luis
Colomer, Dolors
Gómez-Casares, Maria-Teresa
García-Gutiérrez, Valentín
Ortí, Guillermo
Ramírez-Payer, Angel
Olavarria, Eduardo
Vall-llovera, Ferrán
Giraldo, Pilar
Conde, Eulogio
Vallansot, Rolando
López-Lorenzo, Jose Luis
Palomera, Luis
Álvarez-Larrán, Alberto
Conesa, Venancio
Bautista, Guiomar
Casas, Laura
Giles, Frank
Hochhaus, Andreas
Casado-Montero, Luis Felipe
author_sort Steegmann, Juan Luis
collection PubMed
description
format Online
Article
Text
id pubmed-5756548
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-57565482018-01-22 Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase Steegmann, Juan Luis Colomer, Dolors Gómez-Casares, Maria-Teresa García-Gutiérrez, Valentín Ortí, Guillermo Ramírez-Payer, Angel Olavarria, Eduardo Vall-llovera, Ferrán Giraldo, Pilar Conde, Eulogio Vallansot, Rolando López-Lorenzo, Jose Luis Palomera, Luis Álvarez-Larrán, Alberto Conesa, Venancio Bautista, Guiomar Casas, Laura Giles, Frank Hochhaus, Andreas Casado-Montero, Luis Felipe J Cancer Res Clin Oncol Correction Springer Berlin Heidelberg 2017-10-23 2018 /pmc/articles/PMC5756548/ /pubmed/29063181 http://dx.doi.org/10.1007/s00432-017-2532-1 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Correction
Steegmann, Juan Luis
Colomer, Dolors
Gómez-Casares, Maria-Teresa
García-Gutiérrez, Valentín
Ortí, Guillermo
Ramírez-Payer, Angel
Olavarria, Eduardo
Vall-llovera, Ferrán
Giraldo, Pilar
Conde, Eulogio
Vallansot, Rolando
López-Lorenzo, Jose Luis
Palomera, Luis
Álvarez-Larrán, Alberto
Conesa, Venancio
Bautista, Guiomar
Casas, Laura
Giles, Frank
Hochhaus, Andreas
Casado-Montero, Luis Felipe
Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase
title Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase
title_full Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase
title_fullStr Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase
title_full_unstemmed Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase
title_short Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase
title_sort correction to: an analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756548/
https://www.ncbi.nlm.nih.gov/pubmed/29063181
http://dx.doi.org/10.1007/s00432-017-2532-1
work_keys_str_mv AT steegmannjuanluis correctiontoananalysisofthekineticsofmolecularresponseduringthefirsttrimesteroftreatmentwithnilotinibinnewlydiagnosedchronicmyeloidleukemiapatientsinchronicphase
AT colomerdolors correctiontoananalysisofthekineticsofmolecularresponseduringthefirsttrimesteroftreatmentwithnilotinibinnewlydiagnosedchronicmyeloidleukemiapatientsinchronicphase
AT gomezcasaresmariateresa correctiontoananalysisofthekineticsofmolecularresponseduringthefirsttrimesteroftreatmentwithnilotinibinnewlydiagnosedchronicmyeloidleukemiapatientsinchronicphase
AT garciagutierrezvalentin correctiontoananalysisofthekineticsofmolecularresponseduringthefirsttrimesteroftreatmentwithnilotinibinnewlydiagnosedchronicmyeloidleukemiapatientsinchronicphase
AT ortiguillermo correctiontoananalysisofthekineticsofmolecularresponseduringthefirsttrimesteroftreatmentwithnilotinibinnewlydiagnosedchronicmyeloidleukemiapatientsinchronicphase
AT ramirezpayerangel correctiontoananalysisofthekineticsofmolecularresponseduringthefirsttrimesteroftreatmentwithnilotinibinnewlydiagnosedchronicmyeloidleukemiapatientsinchronicphase
AT olavarriaeduardo correctiontoananalysisofthekineticsofmolecularresponseduringthefirsttrimesteroftreatmentwithnilotinibinnewlydiagnosedchronicmyeloidleukemiapatientsinchronicphase
AT valllloveraferran correctiontoananalysisofthekineticsofmolecularresponseduringthefirsttrimesteroftreatmentwithnilotinibinnewlydiagnosedchronicmyeloidleukemiapatientsinchronicphase
AT giraldopilar correctiontoananalysisofthekineticsofmolecularresponseduringthefirsttrimesteroftreatmentwithnilotinibinnewlydiagnosedchronicmyeloidleukemiapatientsinchronicphase
AT condeeulogio correctiontoananalysisofthekineticsofmolecularresponseduringthefirsttrimesteroftreatmentwithnilotinibinnewlydiagnosedchronicmyeloidleukemiapatientsinchronicphase
AT vallansotrolando correctiontoananalysisofthekineticsofmolecularresponseduringthefirsttrimesteroftreatmentwithnilotinibinnewlydiagnosedchronicmyeloidleukemiapatientsinchronicphase
AT lopezlorenzojoseluis correctiontoananalysisofthekineticsofmolecularresponseduringthefirsttrimesteroftreatmentwithnilotinibinnewlydiagnosedchronicmyeloidleukemiapatientsinchronicphase
AT palomeraluis correctiontoananalysisofthekineticsofmolecularresponseduringthefirsttrimesteroftreatmentwithnilotinibinnewlydiagnosedchronicmyeloidleukemiapatientsinchronicphase
AT alvarezlarranalberto correctiontoananalysisofthekineticsofmolecularresponseduringthefirsttrimesteroftreatmentwithnilotinibinnewlydiagnosedchronicmyeloidleukemiapatientsinchronicphase
AT conesavenancio correctiontoananalysisofthekineticsofmolecularresponseduringthefirsttrimesteroftreatmentwithnilotinibinnewlydiagnosedchronicmyeloidleukemiapatientsinchronicphase
AT bautistaguiomar correctiontoananalysisofthekineticsofmolecularresponseduringthefirsttrimesteroftreatmentwithnilotinibinnewlydiagnosedchronicmyeloidleukemiapatientsinchronicphase
AT casaslaura correctiontoananalysisofthekineticsofmolecularresponseduringthefirsttrimesteroftreatmentwithnilotinibinnewlydiagnosedchronicmyeloidleukemiapatientsinchronicphase
AT gilesfrank correctiontoananalysisofthekineticsofmolecularresponseduringthefirsttrimesteroftreatmentwithnilotinibinnewlydiagnosedchronicmyeloidleukemiapatientsinchronicphase
AT hochhausandreas correctiontoananalysisofthekineticsofmolecularresponseduringthefirsttrimesteroftreatmentwithnilotinibinnewlydiagnosedchronicmyeloidleukemiapatientsinchronicphase
AT casadomonteroluisfelipe correctiontoananalysisofthekineticsofmolecularresponseduringthefirsttrimesteroftreatmentwithnilotinibinnewlydiagnosedchronicmyeloidleukemiapatientsinchronicphase